Lawsuits over the drug Reglan (Metoclopramide) fascinate me because of the unique nature of the disorders the drug can cause. Reglan can cause movement disorders like tardive dyskinesia. Individuals suffering from these disorders lose control of their facial muscles and their limbs. It’s incredibly strange to me that temporary use of this drug can cause someone to permanently develop movement disorders.
Below you’ll find an assortment of documents filed in Reglan lawsuits from around the country. If you’d like me to put you in touch with a Reglan lawyer, feel free to email me at justinian at justinian dot us, or use the form to the right.
- Report Filed In Reglan Lawsuit Alleges Reglan Warnings Were Inadequate
- Government Report Discusses Metoclopramide Side Effects
- California Reglan Lawsuit Discusses Side Effects of Reglan and Metoclopramide
- Expert Witness Discusses Reglan Risks in Texas Reglan Lawsuit
- FDA Document Discusses Movement Disorders Associated With Metoclopramide
- Metoclopramide Attorney Files Movement Disorder Lawsuit In West Virginia
- Expert Witness Report Filed In Lawsuit Regarding Adverse Reactions to Reglan
- Expert Witness In Metoclopramide Lawsuit Discusses Tardive Dyskinesia At Length
- Vermont Reglan Lawsuit Alleges That Reglan Label Is False and Misleading With Respect To Reglan
- Tardive Dyskinesia Lawyer Alleges Reglan Black Box Warning Should Have Come Sooner
- Georgia Reglan Lawsuit Alleges Wyeth and Schwarz Pharma Did Not Accurately Disclose Side Effects
- Oklahoma Reglan Lawyers File Movement Disorder Lawsuit Against Wyeth, and Generic Manufacturers
- Reglan Attorney Alleges that Reglan Manufacturers Knowingly Sell a Defective Product
- Movement Disorder Attorneys List Metoclopramide Side Effects In Reglan Lawsuit
- Metoclopramide Attorney Files Movement Disorder Lawsuit in Illinois
- Metoclopramide Lawyers Move For Summary Judgment In Reglan Lawsuit
If you have any questions about this blog post - or anything else on this site - please e-mail me at justinian@dangerousdrugs.us
